Adcendo ApS to Present Data on its Novel ADC Target uPARAP in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2024

/PRNewswire/ -- Adcendo ApS ("Adcendo"), a biotech company focused on the development of first-in-class antibody-drug conjugates (ADCs) for the treatment of...

Related Keywords

Denmark ,San Diego ,California ,United States ,Copenhagen ,Køavn ,Knuuttila ,Landskapet Birkaland ,Finland ,Askainen ,Southwest Finland ,Engelholm ,Sjæand ,American ,Lars Engelholm ,Dominik Mumberg ,Cancer Research ,Finsen Laboratory ,Aurexel Life Sciences ,Novo Holdings ,Clinical Research Immunology ,University Of Copenhagen ,Cancer Invasion Section Of The Finsen Laboratory ,American Association For Cancer Research ,American Association ,Annual Meeting ,Chief Scientific Officer ,Associate Professor ,Cancer Invasion Section ,Life Sciences ,Ysios Capital ,Pontifax Venture Capital ,Adcendo ,